#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA674540	F	Compound was evaluated for minimal inhibitory concentration against Escherichia coli	Escherichia coli	4	ALA1129830	organism-based format	Scientific Literature
2.	ALA858530	F	Compound was evaluated for minimal inhibitory concentration against Listeria monocytogenes	Listeria monocytogenes	4	ALA1129830	organism-based format	Scientific Literature
3.	ALA766466	F	Compound was evaluated for minimal inhibitory concentration against Pseudomonas aeruginosa	Pseudomonas aeruginosa	3	ALA1129830	organism-based format	Scientific Literature
4.	ALA806780	F	Compound was evaluated for minimal inhibitory concentration against Serratia liquefaciens	Serratia liquefaciens	2	ALA1129830	organism-based format	Scientific Literature
5.	ALA810128	F	Compound was evaluated for minimal inhibitory concentration against Staphylococcus aureus	Staphylococcus aureus	4	ALA1129830	organism-based format	Scientific Literature
6.	ALA4136785	F	Antileishmanial activity against Leishmania amazonensis MHOM/BR/1973/M2269 promastigotes after 24 hrs by MTT assay	Leishmania amazonensis	22	ALA4130608	organism-based format	Scientific Literature
7.	ALA4136787	A	Cytotoxicity against BALB/c mouse BMDM after 24 hrs by MTT assay	Mus musculus	22	ALA4130608	cell-based format	Scientific Literature
8.	ALA4136788	T	Selectivity index, ratio of MDL50 for human HepG2 cells to IC50 for drug-sensitive blood stage Plasmodium falciparum 3D7		22	ALA4130608	assay format	Scientific Literature
9.	ALA4136789	A	Cytotoxicity against human HepG2 cells after 24 hrs by MTT assay	Homo sapiens	22	ALA4130608	cell-based format	Scientific Literature
10.	ALA4136790	F	Antileishmanial activity against Leishmania infantum MHOM/BR/1972/LD promastigotes after 24 hrs by MTT assay	Leishmania infantum	22	ALA4130608	organism-based format	Scientific Literature
11.	ALA4136791	F	Antileishmanial activity against Trypanosoma cruzi Y epimastigotes after 24 hrs by MTT assay	Trypanosoma cruzi	22	ALA4130608	organism-based format	Scientific Literature
12.	ALA4136792	F	Antiplasmodial activity against drug-sensitive blood stage Plasmodium falciparum 3D7 by SYBR green 1 staining based fluorescence assay	Plasmodium falciparum	26	ALA4130608	organism-based format	Scientific Literature
13.	ALA4136793	A	Cytotoxicity against human HepG2 cells assessed as morphological changes at 10 uM by microscopic method	Homo sapiens	1	ALA4130608	cell-based format	Scientific Literature
14.	ALA4136794	F	Antiplasmodial activity against chloroquine/cycloguanil/pyrimethamine-resistant blood stage Plasmodium falciparum K1 by SYBR green 1 staining based fluorescence assay	Plasmodium falciparum	5	ALA4130608	organism-based format	Scientific Literature
15.	ALA4136795	F	Antiplasmodial activity against drug-sensitive blood stage Plasmodium falciparum 3D7 ring forms assessed as morphological changes at 10 times IC50 after 8 to 16 hrs by microscopic analysis	Plasmodium falciparum	1	ALA4130608	organism-based format	Scientific Literature
16.	ALA4136796	F	Antiplasmodial activity against chloroquine/cycloguanil/pyrimethamine-resistant blood stage Plasmodium falciparum K1 assessed as morphological changes at 10 times IC50 after 8 to 16 hrs by microscopic analysis	Plasmodium falciparum	1	ALA4130608	organism-based format	Scientific Literature
17.	ALA4136797	F	Synergistic antiplasmodial activity against drug-sensitive blood stage Plasmodium falciparum 3D7 in presence of artesunate	Plasmodium falciparum	1	ALA4130608	organism-based format	Scientific Literature
18.	ALA4136798	F	Synergistic antiplasmodial activity against chloroquine/cycloguanil/pyrimethamine-resistant blood stage Plasmodium falciparum K1 in presence of artesunate	Plasmodium falciparum	1	ALA4130608	organism-based format	Scientific Literature